Skip to main content
https://pbs.twimg.com/media/FheuX_KWQAI2H0V.jpg
DAVIX is a promising surrogate outcome measure of vascular disease in SSc. Questions around cost and access remain. Abs 1541 #ACR22 @RheumNow https://t.co/KJgtcG5ah8 https://t.co/NsK7b8fQFt
Dr. Rachel Tate
13-11-2022
×